U.S. Says Allergan's Forest Units to Pay $38 Million to Settle Kickback Allegations

Source: Reuters

Friday, December 16, 2016 | Corporate Lawsuits

Allergan PLC's Forest Laboratories and Forest Pharmaceuticals units will pay $38 million to settle U.S. charges that it paid physicians to prescribe three medications, the U.S. Justice Department said on Thursday. In a statement, the department said the alleged kickbacks involved the companies' blood pressure hypertension drug Bystolic, fibromyalgia medication Savella and the Alzheimer’s disease product Namend.

Open in New Window


You must be logged in to leave a comment.